Sysmex (6869.T) Stock Price
Sysmex Price
Sysmex (6869.T) Stock | ISIN JP3351100007 | WKN 897966. The current Sysmex stock price is 1,426.5 JPY (2026). Revenue is 516.03 B JPY. Net income is 49.6 B JPY. The P/E ratio is 17.93. Market capitalization is 889.47 B JPY. Sysmex operates in the Health sector.
Revenue has compounded at 9.7% per year over the past 19 years to 508.64 B JPY. Earnings per share have grown at 10.9% per year over the last 19 years. Sysmex's net margin stands at 10.6%, broadly stable from 10.5% several years earlier. Sysmex currently offers a dividend yield of about 2.45%. The payout ratio is around 41% of earnings.
Sysmex stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Sysmex over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sysmex stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sysmex's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Sysmex Price |
|---|
Sysmex Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B JPY) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B JPY) |
| NET INCOME (B JPY) |
| NET INCOME GROWTH (%) |
| DIVIDEND (JPY)DIV. (JPY) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 305.07 | 363.78 | 410.5 | 461.51 | 508.64 | 516.03 | 556.23 | 591.01 |
| 1.02 | 19.24 | 12.84 | 12.43 | 10.21 | 1.45 | 7.79 | 6.25 |
| 50.58 | 52.39 | 52.64 | 52.54 | 53.47 | 52.71 | 48.9 | 46.02 |
| 154.3 | 190.59 | 216.08 | 242.5 | 271.98 | 271.98 | 271.98 | 271.98 |
| 31.91 | 44.09 | 45.78 | 49.64 | 53.67 | 49.6 | 56.57 | 61.7 |
| -8.54 | 38.2 | 3.84 | 8.42 | 8.12 | -7.59 | 14.06 | 9.07 |
| 73 | 79 | 82 | 29 | 35 | 18 | 38.11 | 41.32 |
| 1.39 | 8.22 | 3.8 | -64.63 | 20.69 | -48.57 | 111.72 | 8.42 |
| 627.77 | 628.43 | 627.97 | 626.43 | 623.53 | 623.53 | 623.53 | 623.53 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Sysmex generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sysmex retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sysmex's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Sysmex has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sysmex's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Sysmex stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex business model & stock analysis
Sysmex SWOT Analysis
Strengths
Sysmex Corp is renowned for its advanced medical technology and laboratory testing equipment. This gives the company a competitive advantage in providing cutting-edge diagnostic solutions to healthcare providers worldwide.
With a wide distribution network and well-established subsidiaries in numerous countries, Sysmex Corp has a strong international presence. This allows the company to serve a diverse customer base and explore new market opportunities.
Sysmex Corp invests significantly in research and development, enabling continuous innovation in the medical diagnostics field. This enables them to introduce new products and stay ahead of competitors.
Weaknesses
Sysmex Corp heavily relies on a few key products, which could pose a risk if there is a decline in demand or potential product obsolescence. Diversification of their product portfolio might mitigate this risk.
As a healthcare company, Sysmex Corp operates in a highly regulated industry. Changes in regulations or policies can impact their operations, requiring constant adaptation and compliance efforts.
Opportunities
The increasing healthcare needs of the global population present significant growth opportunities for Sysmex Corp. They can expand their reach and offer innovative solutions to address emerging health challenges.
Sysmex Corp can venture into untapped markets, especially in emerging economies where demand for advanced medical diagnostics is rising. This would help them diversify their customer base and increase revenue streams.
Threats
Sysmex Corp faces strong competition from major players in the medical diagnostics industry. Competitors with similar product offerings and well-established market presence can potentially challenge Sysmex Corp's market share.
Economic downturns or financial instability can affect the healthcare industry, leading to reduced healthcare spending and potential customer budget constraints. Sysmex Corp needs to be prepared to navigate such challenges.
Sysmex Eulerpool Fair Value
Sysmex historical P/E ratio, EBIT multiple, and P/S ratio
Sysmex annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Sysmex shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex Dividend History
33 years of dividend payments
Sysmex dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Sysmex Earnings Estimates
Sysmex Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/9/2024 | 75.11JPY | 126.36 BJPY | 2024 Q4 |
| 2/7/2024 | 61.53JPY | 115.61 BJPY | 2024 Q3 |
| 5/10/2023 | 134.91JPY | 117.56 BJPY | 2023 Q4 |
| 2/8/2023 | 53.59JPY | 105.85 BJPY | 2023 Q3 |
| 11/9/2022 | 21.96JPY | 102.7 BJPY | 2023 Q2 |
| 8/4/2022 | 46.82JPY | 88.14 BJPY | 2023 Q1 |
| 5/12/2022 | 54.05JPY | 99.84 BJPY | 2022 Q4 |
| 2/10/2022 | 56.88JPY | 90.69 BJPY | 2022 Q3 |
| 11/10/2021 | 32.94JPY | 83.91 BJPY | 2022 Q2 |
| 8/6/2021 | 36.67JPY | 75.2 BJPY | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Sysmex stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Sysmex shareholder structure
| % | Name |
|---|---|
6.20529% | |
5.77356% | |
5.5075% | |
3.48162% | |
3.35332% | |
2.75464% | |
2.28537% | |
2.26777% | |
1.97384% | |
1.81236% |
Sysmex Executives and Management Board
Mr. Hisashi Ietsugu
(74)Chairman of the Board, Group Chief Executive Officer, Representative Director · since 1986
Mr. Kaoru Asano
(65)President, Representative Director · since 2009
Mr. Kenji Tachibana
(66)Senior Managing Executive Officer, Director · since 2011
Mr. Iwane Matsui
(63)Senior Managing Executive Officer, Director · since 2011
Mr. Tomokazu Yoshida
(59)Managing Executive Officer, Chief Technology Officer, Director · since 2017
Sysmex Supply Chain
Frequently asked questions about Sysmex
Sysmex Corp is a leading healthcare company specializing in diagnostic testing equipment and technologies. The business model of Sysmex Corp revolves around the design, development, and manufacture of innovative testing systems for clinical laboratories and healthcare institutions. With a strong focus on hematological analysis and hemostasis, Sysmex Corp provides highly accurate and reliable diagnostic solutions to support disease detection, monitoring, and treatment. By leveraging advanced technologies and automation, the company enables efficient and precise diagnostic processes, ultimately contributing to better patient outcomes. Sysmex Corp's business model centers on delivering cutting-edge diagnostic solutions that empower healthcare professionals with the tools they need for accurate and timely diagnoses.
Sysmex stock
Sysmex Ticker
Sysmex FIGI
All fundamentals and in-depth analysis of Sysmex
Our stock analysis for Sysmex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sysmex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.